Adicet Bio, Inc. ( ACET) - Stock Earnings
ACET Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -26.9 million USD | — USD |
| 2025Q4 | -30.5 million USD | — USD |
| 2026Q1 | -20.2 million USD | — USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
ACET Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -142.7 million USD | — USD |
| 2024 | -117.1 million USD | — USD |
| 2025 | -116.8 million USD | — USD |
| 2026 Est. | — | — |
ACET
Price: $8.10
52 week price:
Payout Ratio Range:
Earnings Per Share: -13.87 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 400300
Ebitda: 12.8 millionMarket Capitalization: 77.5 million